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Postnatal organogenesis occurs in an immune
competent environment and is tightly controlled by
interplay between positive and negative regulators.
Innate immune cells have beneficial roles in postnatal
tissue remodeling, but roles for the adaptive immune
system are currently unexplored. Here we show
that adaptive immune responses participate in the
normal postnatal development of a non-lymphoid
epithelial tissue. Since the mammary gland (MG) is
the only organ developing predominantly after birth,
we utilized it as a powerful system to study adaptive
immune regulation of organogenesis. We found that
antigen-mediated interactions between mammary
antigen-presenting cells and interferon-g (IFNg)-pro-
ducing CD4+ T helper 1 cells participate in MG post-
natal organogenesis as negative regulators, locally
orchestrating epithelial rearrangement. IFNg then
affects luminal lineage differentiation. This function
of adaptive immune responses, regulating normal
development, changes the paradigm for studying
players of postnatal organogenesis and provides
insights into immune surveillance and cancer
transformation.
INTRODUCTION
Prenatal organ development takes place in the presence of an
immature immune system and continues after birth as the im-
mune system reaches its full potential. In epithelial organs such
as lung, breast, and intestine, postnatal organogenesis is regu-
lated by communication between epithelial cells and innate im-
mune cells (Reed and Schwertfeger, 2010; Renz et al., 2012).
During this period, the previously immature adaptive immune
system is exposed to antigens and rapidly develops. Therefore,
postnatal development of various epithelial tissues occurs in an
immune-competent environment. However, whether the adap-
tive immune system regulates normal organ development inDevelopmennon-pathologic conditions has yet to be explored. Whereas
other epithelial organs have relatively minor postnatal develop-
mental phases, the mammary gland (MG) is the only organ that
develops predominantly after birth, during puberty (Wiseman
and Werb, 2002). At birth, the MG consists of an epithelial rudi-
mentary tree. In mice, mammary postnatal organogenesis starts
with onset of puberty, at 3–4 weeks of age, and is characterized
by ductal invasion until the growing and branching epithelial
ducts reach the fat pad limits by 8–9 weeks of age (Figure S1A)
(Sternlicht et al., 2006). A secondary expansion occurs with
each estrus andmenstrual cycle in rodents and humans, respec-
tively, as well as during pregnancy and lactation. This secondary
expansion regresses during the process of involution (Watson
et al., 2011). Although steroid and peptide hormones are major
initiators and regulators of mammary postnatal organogenesis,
it is also tightly regulated by intracellular and extracellular signals
between epithelial cells and the surrounding microenvironment
or stroma, which includes extracellular matrix, fibroblasts, adi-
pocytes, and immune cells (Lu and Werb, 2008).
Innate immune cells such as colony-stimulating factor-1
(CSF-1)-dependent macrophages, eotaxin-dependent eosino-
phils (Gouon-Evans et al., 2002), and mast cells (Lilla and
Werb, 2010) are involved in the positive regulation of pubertal
mammary ductal expansion. Interestingly, based on the immune
cells involved, postnatal MG development has been compared
to awound healing process (Reed and Schwertfeger, 2010). Dur-
ingwound healing, antigen-presenting cells (APCs) become acti-
vated and recruit other immune cells, including CD4+ T helper
cells, to create an environment for tissue remodeling. However,
to date, the presence and role of APCs and T cells in the devel-
opment of the mammary organ have not been assessed.
Since in the mouse the MG develops from a rudimentary
epithelial tree to a fully developed organ within the few weeks
of puberty (Sternlicht et al., 2006), it is a powerful model system
to explore whether antigen-mediated interactions between
APCs and tissue T cells contribute to the normal postnatal devel-
opment of non-lymphoid epithelial tissues. To explore roles for
the adaptive immune system in local regulation of mammary
postnatal organ development, we utilized transgenic mouse
models that allowed for genetic ablation or overrepresentation
of immune cell subsets and explored ductal invasion in whole-
mount MGs. In parallel, we also performed live imaging andtal Cell 34, 493–504, September 14, 2015 ª2015 Elsevier Inc. 493
Figure 1. Epithelial-Associated Mammary
CD11c+ Cells Negatively Regulate Branch-
ing Morphogenesis
(A) Immunostaining of CD11c+ cells in MGs of
CD11c-DTR:GFP mice shows co-localization of
these cells to the mammary epithelium (Movie S1).
(B) Experimental design of differential separation,
embedding in Matrigel, culture, and quantification
of epithelial branching in 3D primary mammary
epithelial organotypic cultures (organoids). Orga-
noids initiate as cysts (day 1), which start branch-
ing on day 3 of culture. Quantification of branching
was performed on day 5 unless indicated
otherwise.
(C) Flow cytometry of CD11c-DTR:GFP organoids
24 hr after culture with DTx. Note that organoids
were retrieved from Matrigel, so number of cells
and autofluorescence are a challenge.
(D) Branching of CD11c-DTR:GFP organoids
cultured with DTx. Controls were DTx on WT
and mutated DTx on CD11c-DTR:GFP organoids
(n = 8, 3, and 3 experiments, respectively).
(E) Flow cytometry of CD11c-DTR:GFP epithelial-
associated APCs, 48 hr after a mutant DTx or DTx
injection.
(F) Branching of CD11c-DTR:GFP organoids
cultured from MGs harvested 48 hr after DTx in-
jection (n = 3 experiments).
(G) Schematic depicting mammary CD11c+ cells
as negative regulators of branching.
Data in (D) and (E) are represented as mean ± SEM
See also Figure S1 and Movie S1.functional analyses in primary three-dimensional (3D) organo-
typic mammary branching assays (i.e., organoids).
RESULTS
Epithelial-Associated Mammary CD11c+ Cells
Negatively Regulate Branching Morphogenesis
CD11c is a selective marker for dendritic cells but also for some
macrophages (Engelhardt et al., 2012; Vallon-Eberhard et al.,
2006), both of which have antigen presentation capacities (Gaut-
ier et al., 2012; Miller et al., 2012). We found CD11c+ cells, which
have dendritic-like features, closely associated with the mam-
mary epithelium (Figures 1A and S1B; Movie S1). To study the
role of these CD11c+ cells in mammary postnatal organogen-
esis, we utilized organoids cultured in fibroblast growth factor
2 (FGF2) (Figure 1B), which are well characterized ex vivo
branching models to study postnatal mammary organogenesis
(Ewald et al., 2008). These surrogate assays not only reflect
the ductal elongation aspect of epithelial branching, which de-
pends on cell proliferation and epithelial surface expansion
(Zhang et al., 2014), but also allow the elimination of any organ
non-specific or hormone-dependent effects. To assess whether
these CD11c+ cells influenced MG organogenesis, we used
CD11c-DTR:GFP mice (Jung et al., 2002), which express the
diphtheria toxin receptor under the CD11c promoter. Utilizing or-
ganoids from CD11c-DTR:GFP MGs, we found that CD11c+
cells are closely associated with the mammary epithelium, and
then we depleted them by diphtheria toxin (DTx) administration
either ex vivo during organotypic culture (Figures 1C and 1D)494 Developmental Cell 34, 493–504, September 14, 2015 ª2015 Elsor in vivo before organoid preparation (Figures 1E and 1F).
In both cases, CD11c+ cell depletion accelerated epithelial
branching (Figures 1D, 1F, and S1C–S1E). These data suggest
an inhibitory role for CD11c+ cells in the morphogenesis of
pubertal MGs (Figure 1G).
Epithelial-Associated Mammary CD11c+ Cells Have
Characteristics of APCs
We next characterized the epithelial-associated mammary
CD11c+ cells. Interrogation of molecular markers using surface
stains and transgenic reporters (see Supplemental Experimental
Procedures) revealed that these CD11c+ cells express high
levels of CX3CR1 (Figure 2A), CSF-1 receptor (CSF-1R, using
the c-fms transgene) (Figure 2B), and F4/80 (Figure 2C). Most
interestingly, they express high levels of major histocompatibility
complex (MHC) II (Figure 2D), which is essential for antigen pre-
sentation, as well as intermediate levels of CD11b (Figure 2E).
The absence of Siglec-F expression (Figure S2A) suggested
that these CD11c+ cells are APCs of the monocytic lineage
rather than eosinophils (Gautier et al., 2012; Gouon-Evans
et al., 2000;Miller et al., 2012). In addition, we observed amacro-
phage-type population associated with the organoids, which is
F4/80+, high for CD11b, and low for CD11c and MHCII (Figures
2C and 2E).
We examined the interactions of these CD11c+ APCs with
the mammary epithelium during branching morphogenesis.
Because the fluorescence of CD11c+ cells from the CD11c-
DTR:GFP model is too dim for time-lapse confocal microscopy
and since most CD11c+ cells are CX3CR1+, we used organoidsevier Inc.
Figure 2. Epithelial-Associated Mammary CD11c+ Cells Respond to Epithelial Branching and Present APC Characteristics
(A) Flow cytometry of epithelial-associated CD11c+ cells indicated that almost all of these cells are CX3CR1+. Data were obtained using CX3CR1-GFP/
transgenic mice and gated on single live cells.
(B) Flow cytometry of epithelial-associated CD11c+ cells indicated they are CSF-1R+. Data were obtained using c-fms-E-GFP transgenic mice (c-fms is
transgene for CSF-1R) and gated on single live cells.
(C) Flow cytometry of epithelial-associated CD11c+ cells, gated on single live cells, shows they are F4/80 high.
(D) Flow cytometry of epithelial-associated CD11c+ cells, gated on single live cells, shows they are MHCII high.
(E) Flow cytometry of epithelial-associated CD11c+ cells, gated on single live cells, shows they are CD11b intermediate. These cells are also MHCII high and F4/
80 high. Another population of CD11b high cells are low for MHCII, CD11c, and F4/80+.
(F) Time-lapse microscopy of CX3CR1-GFP/+ organoids (vast majority of CX3CR1+ cells are CD11c+), from culture days 3–15 (Movies S2 and S3). Arrows
indicate proliferating APC (epithelium marked by Cell Tracker red).
(G) Bar graph quantifies APC proliferation in (F) (n = 12 fields).
(H) Arrows point to APC taking up a cellular particle (Movie S4).
See also Figure S2, Movies S2, S3, and S4, and Supplemental Experimental Procedures.from CX3CR1-GFP/+ reporter mice, in which the GFP signal is
considerably brighter (Jung et al., 2000). These experiments
revealed that the CX3CR1+ APCs actively interacted with the
mammary epithelium and proliferated during branching of orga-
noids (Figures 2F and 2G; Movies S2 and S3) and mammary
ductal invasion in vivo (Figure S2B). Interestingly, several studies
report the in situ proliferation of both macrophages and dendritic
cells (Davies et al., 2013; Veres et al., 2013; Ginhoux et al., 2009).
CSF-1 expressed by mammary epithelial cells (Figure S2C)
located at the neck of terminal end buds (Coussens and Pollard,
2011) could contribute to the proliferation of mammary APCs,
which express CSF-1R (Figure 2B). During branching, these
APCs also engulfed cellular particles (Figure 2H; Movie S4), a
prerequisite for antigen presentation by monocyte-derived
APCs.
T Cells Are Involved in the Negative Regulation of
Mammary Organogenesis
Activation of the adaptive immune system requires the presence
of APCs (Hoebe et al., 2004). APCs link the innate and adaptive
immune systems by capturing antigens in tissues and presenting
them to T cells in lymph nodes. After activation, T cells home to
non-lymphoid tissues, where they exert their effector functions
(Hoebe et al., 2004). We therefore asked whether T cells are
also involved, along with CD11c+ APCs, in the negative regula-
tory loop of mammary postnatal organogenesis (Figure 3A).
Significantly, we found a reduction of mammary CD4+ and
CD8+ T cell numbers after depletion of APCs, both in vivo (Fig-
ures 3B and S1C) and in organoids (Figure S3A). These data sug-Developmengest that APCs may regulate epithelial morphogenesis not only
by attracting T cells to or retaining T cells in MGs but also by pre-
venting their death. We reasoned that in order to regulate mam-
mary postnatal organogenesis, T cells would need to interact
closely with the epithelium, and indeed we found CD4+ and
CD8+ T cells closely associated with the mammary ducts (Fig-
ures 3C, S3B, and S3C). Finally, to test whether T cells contribute
to MG organogenesis, we examined TCRa-deficient (Tcra/)
mice, which lack CD4+ and CD8+ T cells. We observed acceler-
ated ductal outgrowth in Tcra/ MGs (Figures 3D and 3E) and
increased branching in Tcra/ organoids (Figure 3F), supporting
an inhibitory role for CD4+ T cells, CD8+ T cells, or both in MG
organogenesis.
Antigen Presentation via MHCII to CD4+ T Cells
Negatively Regulates Mammary Organogenesis
We next sought to determine which T cell type was involved
in the regulation of MG morphogenesis. For this purpose we
used organoid cultures that, similar to intact MGs, also con-
tained T cells (Figure 4A). In addition to their role in the lymph
node, APCs may reactivate T cells within non-lymphoid tissues
(Broz et al., 2014; Honda et al., 2014). To determine whether
APCs regulate mammary organogenesis through T cells, we
inhibited MHC-mediated APC-T-cell activation with blocking an-
tibodies (Banchereau and Steinman, 1998). Inhibiting MHCII-
mediated CD4+ T cell stimulation resulted in accelerated
branching (Figure 4B), whereas inhibiting MHCI-mediated
CD8+ T cell stimulation had no effect. These data suggest that
antigen presentation to CD4+ T cells may be involved in thetal Cell 34, 493–504, September 14, 2015 ª2015 Elsevier Inc. 495
Figure 3. T Cells Are Involved in the Negative Regulation of Mam-
mary Organogenesis
(A) Schematic depicting the question of whether APC may negatively regulate
MG postnatal organogenesis via interaction with T cells.
(B) Flow cytometry of CD4+ and CD8+ T cells (gated on CD3+), 48 hr post-
PBS/DTx injections to CD11c-DTR (n = 6 MGs).
(C) Immunohistochemistry shows co-localization of CD4+ and CD8+ T cells to
mammary epithelium in intact glands.
(D) Comparison of epithelial ductal outgrowths from carmine-red-stained MG
whole mounts from WT and Tcra/ mice.
(E) Quantification of ductal outgrowths in (D) (n = 8 WT and 4 Tcra/ MGs).
(F) Increased branching in Tcra/ organoids (n = 3 experiments).
Data in (B), (E), and (F) are represented as mean ± SEM. See also Figure S3.negative regulation of mammary organogenesis. Antigen pre-
sentation requires the close association of APCs and T cells.
Indeed, CD11c+ APCs and CD4+ T cells were in close proximity
and co-localized to the mammary epithelium in sections of pu-
bertal MGs (Figure 4C). To confirm that epithelial-associated
mammary APCswere capable of T cell activation via antigen pre-496 Developmental Cell 34, 493–504, September 14, 2015 ª2015 Elssentation, we measured T cell proliferation by co-culturing
organoids with ovalbumin (OVA)-specific (OT-II) CD4+ T cells.
In this system, only presentation of their cognate peptide antigen
(pOVA) by APCs will cause the activation and proliferation of
these OT-II-naive CD4+ T cells. Indeed, upon the addition of
pOVA to the culture media, OT-II T cells proliferated extensively
(Figures 4D, S4A, and S4B). To further test whether the presence
and activation of CD4+ T cells is important for MG organogen-
esis in vivo, we utilized MHCIIflox/ (fl/) 3 CD11c-cre mice,
which are devoid of CD4+, but not CD8+ T cells, due to lack of
MHCII expression on CD11c+ APCs (Figure S4C). MGs from
these mice showed accelerated ductal outgrowth (Figures 4E
and 4F) and increased organoid branching (Figure 4G). Taken
together, these results suggest a negative regulatory role for
CD4+ T cell activation in MG organogenesis (Figure 4H).
CD4+ Th1 Cells Negatively Regulate Mammary
Organogenesis
Since CD4+ effector T cells function as distinct subsets (e.g.,
Th1, Th2, Th17, and T regulatory cells) specialized for specific
adaptive immune responses (Zhu et al., 2010), we next asked
which subset regulates MG organogenesis. By flow cytometric
analysis, we observed predominantly the Th1 phenotype within
MGs (Figures 5A and S5A). We therefore determined whether
activation of CD4+ Th1 cells could inhibit mammary epithelial
morphogenesis by adding these cells to the organoid cultures
and stimulating the cultures with the pOVA peptide. Even though
CD4+ Th2 cells are very rare in pubertal MGs, we included these
cells in our analysis because they often counteract the effects of
CD4+ Th1 and therefore may yield opposing results. Using time-
lapse confocal microcopy, we noticed that Th1 and Th2 cells
both interacted with MG APCs (Figure S5B; Movies S5 and
S6), and dye-dilution experiments showed that antigen presen-
tation induced their proliferation (Figure 5B). Interestingly, while
Th1-polarized OT-II cells inhibited branching, the presence of
Th2 cells increased branching (Figures 5C and S5C). Remark-
ably, only the addition of pOVA to the OVA-specific effector
T cell-organoid co-cultures caused the significant decrease or
increase in branching, suggesting that T cell activation by mam-
mary APCs is required in situ in order to regulate MG organogen-
esis. However, since culturing the Th1 or Th2 cells in the pres-
ence of interleukin (IL) 2 likely promoted the production of their
effector cytokines (Zhou et al., 2003), this could explain the
respective initial negative or positive effect they still had on
branching even without pOVA (Figure 5C). Interestingly, deple-
tion of APCs from the T cell-organoid co-cultures rescued the
effect that OVA-specific Th1 (and Th2) cells had on branching
(Figure S5D), validating a role for in situ antigen presentation.
The reduction in T cell numbers after depletion (Figures 3B and
S3A) may further suggest that restimulation from local tissue
APCs is required for T cell survival. Moreover, in support of this
notion, we observed that mammary organoids from OT-II mice
that are naturally enriched with OVA-specific Th1 cells exhibited
decreased branching when cultured with pOVA (Figure 5D).
Given that Th1 effector cells are the predominant CD4+ T cells
withinMGs, the accelerated branching of wild-type (WT) organo-
ids after blockade of MHCII (Figure 4B) also suggested that
in situ antigen presentation to epithelial-associated CD4+ Th1
cells plays a role in organoid branching.evier Inc.
Figure 4. Antigen Presentation to CD4+ T Cells Negatively Regulates Mammary Organogenesis
(A) Flow cytometry of MHCII+ CD11c+ APCs and CD3+ T cells (which marks both CD4+ and CD8+ T cells) associated with organoids.
(B) Branching of organoids cultured with blocking antibodies to MHCI, MHCII, or CD4 quantified relative to respective isotype controls (red line; n = 5
experiments).
(C) Immunohistochemistry shows co-localization of CD11c+ APCs, CD4+ T cells, and mammary epithelium in intact glands. Cell nuclei are stained with DAPI.
(D) Naive eFluor-670-labeled OVA-specific CD4+ (OT-II) T cells proliferate when co-cultured with organoids and pOVA (n = 5 experiments; a representative
histogram is presented. Cell counts: OT-II no pOVA: 87; OT-II +pOVA: 1,656).
(E) Comparison of epithelial ductal outgrowths from MHCIIfl/ control versus MHCIIfl/ 3 CD11c-cre MG whole mounts.
(F) Quantification of outgrowths in (E) (n = 4 control and 8 MHCIIfl/ 3 CD11c-cre MGs).
(G) Increased branching in MHCIIfl/ 3 CD11c-cre organoids (n = 3 experiments).
(H) Schematic depicting APC and CD4+ T cell interactions via MHCII mediating mammary postnatal organogenesis.
Data in (B), (F), and (G) are represented as mean ± SEM. See also Figure S4.We next examined the role of CD4+ Th1 cells in mammary
postnatal organogenesis in vivo. Given the MG Th1 dominance,
the MHCIIfl/ 3 CD11c-cre mice lacking CD4+ T cells (Figures
4E–4G) effectively served as a model devoid of mammary Th1
cells. For a mouse model with an overrepresentation of CD4+
Th1 cells within MGs, we exploited the integrin b8flox/flox (fl/fl) 3
CD11c-cre mice, which have increased frequency and number
of Th1 cells, while all other MG CD4+ T cell subsets are dimin-
ished (Figures 5F, S5E, and S5F). Importantly, these mice show
no change in CD11c+ cell number or phenotype (Travis et al.,
2007; Melton et al., 2010). The b8fl/fl 3 CD11c-cre mice demon-
strated significantly impaired MG ductal invasion, reinforcing the
role of Th1 cells as the relevant negative regulatory subset within
MGs (Figures 5G and 5H).We also observed blunted branching in
organoids from these Th1-enhanced b8fl/fl 3 CD11c-cre MGs
(Figures 5I, S5G, and S5H). To confirm that the impaired organo-
genesis of b8fl/fl 3 CD11c-cre mice depends on increased fre-
quency and numbers of Th1 cells rather than defective APCs,
we crossed b8fl/fl 3 CD11c-cre mice to severe combined immu-
nodeficiency (SCID) mice, which lack T (and B) cells, and found
that levels of MG ductal growth and branching were similar to
those of SCID littermates (Figures 5J–5L). Moreover, since the
b8fl/fl 3 CD11c-cre is the only model thus far that exhibited in-
hibited branching, we examined the MGs from older mice and
found that the blunted branching of b8fl/fl3 CD11c-cre MGs per-
sisted beyond puberty (Figure 5M). Interferon-g (IFNg) secreted
by Th1 cells participates in driving Th1 differentiation down-Developmenstreamof IL-12 fromnaive T cells in a positive feedback loop (Ma-
gram et al., 1996). In the absence of IFNg, most CD4+ T cells fail
to differentiate into the Th1 effector phenotype (Ishii et al., 2013).
We therefore crossed the b8fl/fl3 CD11c-cre mice into the IFNg-
deficient background (Ifng/). MGs from Ifng/b8fl/fl3 CD11c-
cre mice revealed comparable ductal invasion and organoid
branching to Ifng/ controls (Figures S5I–S5K). These data
further propose that the excess of Th1 cells in b8fl/fl 3 CD11c-
cre MGs led to their impaired development. To this end, our
data suggest that tissue antigen presentation by mammary
CD11c+ APCs and reactivation of CD4+ Th1 cells play roles in
the negative regulation of MG organogenesis (Figure 5N).
IFNgMediates the Inhibitory Effect of CD4+ Th1Cells on
Mammary Organogenesis by Affecting Luminal
Differentiation
IFNg is the primary effector cytokine secreted by Th1 cells
(Schoenborn and Wilson, 2007; Zhu et al., 2010) and is also a
characteristic of mammary CD4+ Th1 cells (Figures 5A and
S5A). Morphological changes of branching epithelial organs
are governed by a meticulous local regulation of epithelial rear-
rangement (Ewald et al., 2008). To determine whether IFNg
can mediate the effects of Th1 cells on mammary organogen-
esis, we first tested whether it has a direct effect on mammary
epithelial cells. The mammary epithelium consists of luminal
and basal lineages, which are characterized by specific surface
markers and cytokeratins (Figure S6A) (Rios et al., 2014; Shehatatal Cell 34, 493–504, September 14, 2015 ª2015 Elsevier Inc. 497
Figure 5. Antigen Presentation to CD4+Th1 Effector Cells Negatively Regulates Mammary Organogenesis
(A) CD4+ T cell subsets in pubertal MGs based on flow cytometry data. Other CD4+ cells are naive or non-activated cells.
(B) In vitro differentiated Th1- and Th2-polarized OVA-specific CD4+ (OT-II) T cells proliferate when co-cultured with organoids and pOVA (n = 3 experiments)
(Movies S5 and S6). Figure shows representative histograms. Counts: Th1 no pOVA: 165; +pOVA: 1,798. Counts: Th2 no pOVA: 158; +pOVA: 451.
(C) In vitro differentiated Th1- or Th2-polarized OT-II cells decreased and increased branching, respectively, when co-cultured with organoids. The addition of
pOVA alone did not affect branching as compared to IL-2 control. However, the addition of pOVA to the OVA-specific effector T-cell-organoid co-culture caused
the significant decrease or increase in branching, suggesting that antigen presentation by MHCII+ CD11c+ APCs (the only MHCII-high cells associated with
organoids) plays a significant role in mediating the effect of these effector T cells on organogenesis (n = 3 experiments).
(legend continued on next page)
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Figure 6. IFNg Mediates the Inhibitory Effect of CD4+Th1 Cells on Mammary Organogenesis by Affecting Luminal Differentiation
(A) Transient nuclear STAT1 phosphorylation (pSTAT1), 30 min after IFNg exposure, that disappears after 2 hr. Insets show high magnifications of the immu-
nostained organoids without the nuclear staining. Borders of nuclei (DAPI) are designated.
(B) pSTAT1 is localized to nuclei of luminal cells (KRT8+) in organoids. The magnification of the boxed area shows pSTAT1 signal without the nuclear staining.
(C) Reduced branching in organoids incubated with IFNg (n = 4 experiments).
(D) qPCR on luminal cells sorted from organoids incubated with IFNg (n = 7 experiments).
(E) IFNg blocking antibodies increase branching in b8fl/fl 3 CD11c-cre organoids (n = 3 experiments).
(F) Accelerated branching in IFNgR1/ organoids (n = 3 experiments).
(G) Schematic depicting CD4+ Th1 cells as inhibitors of mammary organogenesis via IFNg by affecting luminal differentiation.
Data in (C)–(F) are represented as mean ± SEM. See also Figure S6.et al., 2012). Luminal cells express cytokeratin (KRT) 8 and basal
cells express KRT14. In addition, in mouse MGs, both lineages
are positive for the surface marker epithelial cell adhesion mole-
cule (EpCAM). Basal cells express lower levels of EpCAM,
but they are high for CD49f. We incubated mammary organoids
with IFNg and observed a transient nuclear translocation of
phosphorylated STAT1 (pSTAT1), a hallmark of IFNg receptor
(IFNgR) signaling (Figures 6A and S6B). The nuclei of mammary
luminal cells (marked by KRT8) were positive for pSTAT1 in
confirmation of previous findings (Figure 6B) (Khalkhali-Ellis
et al., 2008; Zhu et al., 2010). Corroborating the activation of
IFNgR signaling in luminal cells, we also observed enriched(D) The addition of pOVA to organoids from OT-II 3 CD2-RFP mice (bearing only
cells associated with the organoids were reactivated with the addition of their co
(E) Flow cytometry of Th1 cells.
(F) Analysis of CD4+ T cell subpopulations in control and b8fl/fl 3 CD11c-cre mic
(G) Comparison of epithelial ductal MG outgrowths from control versus b8fl/fl 3 C
(H) Quantification of ductal outgrowths from (G) (n = 6 MGs each).
(I) Decreased branching in b8fl/fl 3 CD11c-cre organoids (n = 3 experiments).
(J) Comparison of epithelial ductal MG outgrowths from SCID control versus SC
(K) Quantification of ductal outgrowths from (J) (n = 4 control; n = 6 b8fl/fl 3 CD1
(L) Comparable branching of SCID control and b8fl/fl 3 CD11c-cre organoids (n =
(M) Decreased branching in b8fl/fl 3 CD11c-cre MGs persists beyond puberty
organogenesis in all other models examined here), with blunted ductal outgrowths
of age (n = 4 MGs each).
(N) Schematic depicting antigen presentation to CD4+ Th1 cells negatively regul
Data in (C), (D), (F), (H), (I), (K), and (L) are represented as mean ± SEM. See also
Developmenexpression of IFNgR1 in the luminal fraction of organoids (Fig-
ure S6C). This is in keeping with previous studies showing
IFNgR1 and IFNgR2 expression in cultured normal human mam-
mary epithelial cells, which represent a mixture of luminal and
basal cell populations based on their cytokeratin expression
(Khalkhali-Ellis et al., 2008), while proteomic profiling revealed
that IFNgR1 is present only on a subset of luminal progenitors
in vivo (Ji et al., 2011). Functionally, we found that incubation
of organoids with IFNg inhibited branching (Figure 6C), confirm-
ing an inhibitory role for IFNg in mammary morphogenesis.
Given that IFNg signaling affects mammary epithelial branch-
ing, we examined the effects of IFNg on mammary epithelialOVA-specific Th1 cells) inhibited branching, suggesting that the effector OT-II
gnate peptide antigen (n = 3 experiments).
e (n = 4 control; n = 8 b8fl/fl 3 CD11c-cre MGs).
D11c-cre mice.
ID b8fl/fl 3 CD11c-cre mice.
1c-cre MGs).
3 experiments).
. These MGs showed inhibited postnatal organogenesis (versus accelerated
persisting beyond the pubertal organogenesis phase, as examined at 9 weeks
ating mammary organogenesis.
Figure S5 and Movies S5 and S6.
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lineage determination. Indeed, gene profiling of mammary orga-
noids after incubation with IFNg and sorting into the luminal and
basal cell populations (Figure S6C) confirmed that IFNg affects
the luminal lineage by downregulating the expression of some
mature and progenitor luminal cell markers (Figure 6D). We
found a significant reduction in the expression of the luminal pro-
genitor markers Cd49b and Cd14 (Shehata et al., 2012). We also
found a significant decrease in expression of the mature luminal
markers progesterone receptor (Pgr), Gata3, and Muc1. The
expression of the luminal progenitor marker Elf5 did not
change. Lmo4 and Mfge8, two other luminal markers, also did
not significantly change in expression following incubation with
IFNg (Shehata et al., 2012). Although the luminal marker Krt8
decreased, the change in its expression was not statistically sig-
nificant, similar to Ifngr1. These results imply that branching in or-
ganoids cultured in FGF2, which reflects ductal elongation and is
governed by proper luminal differentiation, is disrupted by IFNg.
Even though we detected no significant change in the overall fre-
quency of luminal cells (Figure S6C), we found increases in both
proliferation and apoptosis of cells located within the lumens of
IFNg-treated organoids (Figures S6D and S6 E), reinforcing
that changes occur within the luminal population. The effects
on the basal lineage were not significant for the progenitor and
basal markers tested (Figure S6F).
Last, we investigated how significant is IFNg secreted by
CD4+ Th1 cells to mammary epithelial branching and whether
CD4+ Th1 cells could regulate the mammary epithelium through
factors other than IFNg. For this purpose we added IFNg-
neutralizing antibodies to organoid cultures with excessive
numbers of CD4+ Th1 cells and found that these cultures
showed significantly accelerated branching (Figure 6E). Simi-
larly, organoids from Ifngr1/ mice, which like Ifng/ mice do
not have properly functioning Th1 cells, showed accelerated
branching (Figure 6F). Taken together, our data suggest that
Th1 cells inhibit mammary organogenesis by locally inhibiting
luminal differentiation through IFNg secretion (Figure 6G).
DISCUSSION
In this study we have investigated whether the adaptive immune
system locally contributes to postnatal mammary organogen-
esis. By using the postnatal MG as a model of immune-compe-
tent organ development, we have demonstrated a role for the
adaptive immune system in regulating organogenesis of a non-
lymphoid epithelial tissue. We provide compelling evidence
that antigen-mediated interactions between mammary CD11c+
APCs and CD4+ IFNg+ Th1 cells provide signals that negatively
regulate ductal invasion. We show that mammary epithelial
cells respond directly to IFNg. These effects are reinforced by
enriched expression of IFNgR1 on mammary luminal epithelial
cells and activation of downstream signaling pathways upon
IFNg stimulation. This response participates in orchestrating
epithelial rearrangement by locally affecting luminal epithelial
differentiation.
Although the nature of the antigen or antigens involved re-
mains to be discovered, the significance of our findings is several
fold. First, we recognized an engagement or reactivation of the
adaptive immune system in the regulation of normal epithelial
organ architecture, under non-pathologic conditions. Second,500 Developmental Cell 34, 493–504, September 14, 2015 ª2015 Elsthese results have implications for understanding immune sur-
veillance. Third, the data raise interesting questions regarding
possible roles for T cell dysfunction in pathologic organ remod-
eling as in early stages of breast cancer transformation.
APCs versus Other Innate Immune Cells Implicated in
Mammary Organogenesis
Several seminal papers over the last two decades have demon-
strated roles for mast cells, eosinophils, andmacrophages in ter-
minal end bud elongation during postnatal MG organogenesis
(Coussens and Pollard, 2011; Gouon-Evans et al., 2000; Lilla
and Werb, 2010; Van Nguyen and Pollard, 2002). Macrophages
also have a role in regulating epithelial cell death during post-
partum MG involution (O’Brien et al., 2012).
Csf1op/op mice and Csf1/ mice, both lacking F4/80+ CSF-
1R+macrophages, exhibit decreased terminal end bud numbers
and reduced mammary duct length, and branching during pu-
berty (Dai et al., 2002; Gouon-Evans et al., 2000; Van Nguyen
and Pollard, 2002). This phenotype is consistent with CSF-1R+
cells positively regulating ductal elongation. The mammary
CD11c+ APCs that we describe here are also F4/80+ and
CSF1-R+, yet these cells negatively regulate MG development.
However, we also found a larger population of F4/80+ cells
closely associated with the mammary epithelium, which ex-
presses higher levels of the macrophage marker CD11b but is
low for CD11c and MHCII (Figure 2E). These potentially imma-
ture or non-activated macrophages could be part of those
macrophages previously described as positive regulators of
mammary pubertal development (Gouon-Evans et al., 2000).
Since the Csf1op/op study does not characterize epithelial-
associated cells differentially, but rather examines the MG
stroma as a whole, there may potentially be additional F4/80+
and CSF1-R+ populations located in distant stroma. Indeed,
F4/80+ eosinophils, which are also lacking in Csf1op/op mice
and have been identified as positive regulators of mammary
ductal morphogenesis (Gouon-Evans et al., 2000), are almost
exclusively located in the distant stroma fraction (Figure S2A).
Therefore, it seems that our study identified a discrete popula-
tion of CSF-1R+ APCs within the mammary stromal milieu,
with opposing regulatory potential or location to those cell types
identified in the studies onCsf1op/opMGs. The fact that very little
is known about the negative regulators of mammary postnatal
organogenesis further adds to the value of this study. Since pos-
itive and negative regulators need to act in concert to orchestrate
organogenesis, it will be interesting to examine how these cells
strike the balance for proper MG postnatal organogenesis
and whether antigen-mediated interactions participate in other
stages of mammary morphogenesis such as pregnancy, lacta-
tion, and involution.
Downstream Effects of the Th1 Effector IFNg on
Mammary Epithelial Cells
In the present study, we focused on IFNg, which is the cytokine
characteristic of Th1 effector T cells, the predominant CD4+
effector T cell subset in the developing MG. We showed that
IFNg mediates the effect of Th1 cells on postnatal mammary
organogenesis and acts directly on epithelial cells, as demon-
strated by the transient nuclear translocation of pSTAT1 after
IFNg stimulation. Gene profiling of mammary organoids revealedevier Inc.
changes in mature and progenitor luminal cell markers, most of
which exhibited decreased expression after incubation with
IFNg. Our results are reinforced by a recent study, demon-
strating a role for STAT1, the downstream target of IFNg, in
MG development (Chan et al., 2014). This study showed that
there is a significant increase in the number of alveolar buds in
Stat1/ mice as compared with WT mice and that excessive
bud formation is observed in mature Stat1/ mice. Although
no T cell data or treatment with IFNg was examined, the authors
suggest that signaling via STAT1 negatively regulates luminal
progenitor cells, as loss of STAT1 results in an expansion of
CD61+ luminal progenitor cells, similar to the effects of loss of
IFNg in our study. Specifically, we show that organoids exposed
to IFNg exhibit significantly reduced expression of CD49b, a
marker for mammary luminal progenitor cells. This CD49b+ pop-
ulation also includes IFNgR1-expressing CD61+ cells (Ji et al.,
2011; Shehata et al., 2012).
Furthermore, in our experiments we observed that exposing
organoids to activated Th2 cells induces accelerated branching
(Figure 5C). This is in line with data showing that epithelial-
secreted Th2 type cytokines IL-4 and IL-13, along with their
downstream activators STAT6 and GATA3, promote luminal dif-
ferentiation during alveolar expansion throughout gestation
(Khaled et al., 2007). Together, this supports the idea that
T cell effector cytokines directly regulate mammary epithelial
cells. While we did not find a role for CD8+ T cells in our study,
these cells also secret IFNg upon activation (Schoenborn and
Wilson, 2007) and thus may still have roles in mammary organo-
genesis. We do not rule out the potential existence of pathways
alternate to the one we have delineated in this study.
As a side note, our study does not argue that disrupted adap-
tive immune regulation would necessarily have fatal effects on
mammary ductal invasion but rather suggests a role for adaptive
immune regulation as an important homeostatic modulator of
normal epithelial development. Since mice have ten MGs, they
could potentially still nurse pups even if the epithelia in some or
all glands are partially impaired or fail to cover the entire fat pad.
Implications for Cancer Progression
Immune surveillance is an important factor in preventing tumor
growth, andmechanismsof normal organogenesis are frequently
disruptedduring cancer progression.Our data suggest that a Th1
bias in normal MGs restricts epithelial branching. By interacting
with IFNg+ Th1 cells, APCs may be part of a positive feedback
loop as IFNg induces MHCII expression that further drives local
Th1 responses (Biswas and Mantovani, 2010; Strutt et al.,
2010). In contrast, breast tumor models are characterized by a
Th2 bias (Czarneski et al., 2001; Jensen et al., 2003). Our obser-
vation of increased branching in Th2-organoid co-cultures
echoes the observation of Th2 cells dominating mammary ade-
nocarcinomas and promoting invasion as well as pulmonary
metastasis (DeNardo et al., 2009). In fact, numerous findings in
cancer research imply that survival and differentiation of mam-
mary epithelial cells that form tumors are indeed regulated by a
delicate balance between Th1/Th2 signaling.
A Th1 bias is more effective in tumor rejection. It has been
shown that the combined action of the Th1 cell cytokines,
IFNg, and tumor necrosis factor (TNF) induces permanent
growth arrest and drives breast and other cancers into senes-Developmencence (Braumu¨ller et al., 2013). This cytokine-induced senes-
cence strictly requires STAT1 and TNFR1 signaling, respectively.
Moreover, in an estrogen receptor (ER) a+ luminal type human
breast cancer model that is heavily infiltrated by innate immune
cells and T lymphocytes (Bos et al., 2013), IFNg and CD4+
T cells (but not NK or CD8+ T cells) show anti-tumor activity
and inhibit metastatic tumor progression via extensive apoptotic
tumor cell death. Other studies imply that immune escapemech-
anisms in ERa+ breast cancer may be facilitated through an ERa
suppressive mechanism on IFNg signaling (Mostafa et al., 2014).
Indeed, in a mouse model of human epidermal growth factor re-
ceptor (HER) 2-positive breast cancers, tumor cells control the
outcome of tumor immune surveillance through modulation of
IFNgR1 expression on tumor cells. Those that express low levels
of IFNgR1 fail to be eliminated by IFNg-producing CD8+ T cells
and remain dormant and quiescent until they conceal them-
selves from the adaptive immune system by losing the tumor an-
tigen, Neu (Kmieciak et al., 2013). Finally, using a Stat1 floxed
model that permits tissue-specific disruption of STAT1 in mam-
mary epithelium and a model of HER2-positive breast cancer
(Neu/ERBB2-induced) allowed the investigators to identify a
role for STAT1 in mammary tumor suppression separate from
its role in the immune system, (Klover et al., 2010). This is also
in line with the findings that Stat1-deficient mice develop ERa+
mammary tumors (Chan et al., 2014).
Our work warrants future studies examining how the adaptive
immune system modulates the fate of normal epithelial and
cancer cells. A follow-up study could then focus on the transition
between positive and negative regulation during the different cy-
cles of MG expansion and involution and during early mammary
carcinogenesis. Understanding how this switch occurs and what
impact it has on the epithelium could identify potential targets for
intervention.EXPERIMENTAL PROCEDURES
Experimental Animal Models
Experiments were approved by the UCSF Institutional Animal Use and Care
Committee. CX3CR1-GFP/+, CD11c-DTR:GFP, c-fms-EGFP, Tcra/ and
MHCIIfl/ 3 CD11c-cre, OT-II 3 CD2-RFP, and integrin b8fl/fl 3 CD11c-cre
(also crossed to SCID or Ifng/) mice were on the C57BL/6 background.
In Vivo Depletion of CD11c+ Antigen-Presenting Cells
CD11c-DTR:GFP mice were depleted of APC by injecting diphtheria toxin
(DTx; 4 ng/g weight; Sigma) intraperitoneally (i.p.) and were harvested 48 hr
postinjection (see scheme in Figure S1C). Mutant DTX (4 ng/g weight)
was injected as a control for possible DTx-activated epidermal growth factor
(EGF) signaling.
Mammary Whole-Mount Carmine Staining and Analysis of Ductal
Invasion
Inguinal (number 4) MGs excised at 7 weeks (no significant fat-pad size differ-
ence between littermates) were stained with carmine red andmanually imaged
with a Leica dissection scope using Nikon ACT-1 software. Data were quanti-
fied in a blind fashion.
Immunostaining of Intact Mammary Glands
MGswere fixed, and frozen sections were stained with anti-CD4 (eBioscience,
16-0041-82, 1:500), anti-CD8a (eBioscience, 16-0081-82, 1:500), and anti-
GFP (CD11c-DTR:GFP; Abcam, ab5450, 1:200) antibodies and mounted
with Vectashield + DAPI (Vector Laboratories) for nuclear staining.tal Cell 34, 493–504, September 14, 2015 ª2015 Elsevier Inc. 501
3D Organotypic Culture and Analysis
MGs (numbers 3, 4, and 5 without lymph nodes) were digested in collagenase
solution consisting of DMEM/F12, 2 mg/ml trypsin (GIBCO-BRL), 2 mg/ml colla-
genase IV (Sigma), 10% fetal bovine serum (FBS), 0.5% insulin, and 0.1%
gentamicin (UCSF Cell Culture Facility) and then treated with DNase (2U/ml)
(Sigma). Organoids were epithelial-enriched by differential centrifugations
(pulsed to 1,500 rpm), plated (50–100 organoids/well and 3–4 wells/condition)
with Growth Factor Reduced Matrigel (BD Biosciences), and cultured in
DMEM/F12 with 1% Pen/Strep, 1% insulin, transferrin, sodium selenite, and
supplemented with 2.5 nM FGF2 (Sigma). Ex vivo depletion of CD11c+
APCs is achieved by mixing organoids with DTx (1 mg/ml) before plating.
mutant DTx (1 mg/ml) was added to control for DTx-activated EGF signaling.
For some experiments, blocking antibodies were added to organoid cultures:
0.5 mg/ml anti-MHCII (14-5321-82; eBioscience), Rat IgG2b K Isotype
Control (16-4031-81; eBioscience), and 1 mg/ml anti-MHCI (16-5999-82;
eBioscience), anti-CD4 (16-0041-82; eBioscience) and Mouse IgG2a K Iso-
type Control (16-4724-81; eBioscience). For IFNg blocking, 0.2 mg/ml of anti
IFNg (Clone XMG1.2, BioXCell) was used. IFNg stimulation experiments
were performed by adding IFNg (PeproTech, #315-05, 5 ng/ml) on day 3 of cul-
ture. Organoids were graded by direct manual examination of the culture wells
on days 5, 6, and 7. Branching quantifications are shown for day 5 of culture,
unless otherwise indicated. Images were taken on a ZeissAxio Observer A1 in-
verted microscope, using DFC400 camera and Leica application suite version
3 software (see additional description in Figure 1B).
Fixation and Staining of Organotypic Cultures
Matrigel drops were fixed and embedded in optimal cutting temperature
(O.C.T.). Sections (20 mm) were stained with antibodies against pSTAT1
(Tyr701, Cell Signaling, 9167), GFP (for CD11c-DTR:GFP, Abcam, ab5450,
1:200), CD4 (eBioscience cat. no.: 16-0041-82, 1:200), cytokeratin 8 (Troma
1, Developmental Studies Hybridoma Bank, 1:50), phospho-histone H3 (Cell
Signaling cat. no.: 9701,1:200), and cleaved caspase 3 (Cell Signaling cat.
no.: 9661,1:200), imaged with a spinning disk confocal microscope and quan-
tified using ImageJ.
Flow Cytometry
Single cells were isolated from MGs with collagenase solution similar to orga-
noids but without trypsin in the digest. Differential centrifugations were used to
isolate stroma versus epithelial-enriched fractions. For non-T-cell immune
populations, samples were trypsinized and then incubated with RBC lysis
buffer for red blood cell removal. Stainings were for CD11b, CD3, CD8, CD4,
F4/80, MHCII, and Siglec-F (eBioscience). Intracellular cytokine analysis was
performed as previously described (Melton et al., 2010). In brief, cells were
incubated for 4 hr at 37C in complete RPMI containing 50 ng/ml phorbol myr-
istate acetate (PMA) (Sigma-Aldrich), 1 mM ionomycin (Sigma-Aldrich), and
2 mM monensin (eBioscience). Cells were blocked with PBS containing 2 mg/
ml a-CD16/32 (UCSF Hybridoma Core) and 10% heat-inactivated normal rat
serum (Sigma-Aldrich) and incubated with cell-surface antibodies and Aqua
Live/Dead Fixable Dead cell stain (Invitrogen). Cells were fixed and permeabi-
lized with Fix/Perm solution (eBioscience). Intracellular cytokines were labeled
with antibodies in permeabilization buffer (eBioscience). Data were acquired
using BD LSRII and analyzed with FlowJo. The following antibodies (BD Bio-
sciences or eBioscience) were used: anti-CD4 (clone RM4-5), anti-CD8 (clone
53-6.7), anti-IL-17 (Th17+ CD4+ T cells, clone eBio17B7), anti-IFN-g (Th1
effector CD4+ T cells, clone XMG1.2), anti-Foxp3 (T regulatory cells, clone
FJK-16 s), and anti-IL-13 (Th2 effector CD4+ T cells, clone eBio13A).
In vivo proliferation was assessed by BrdU incorporation: 100 ml BrdU
(10 mg/ml; BD PharMingen) was injected i.p. Single cells from MGs were iso-
lated as described above 2 hr postinjection, stained for extracellular surface
markers, fixed, and permeabilized using the BD (Becton Dickinson) Cytofix/
Cytoperm buffer (15 min at RT). The next day, intracellular BrdU was stained
overnight using the fluorescein isothiocyanate (FITC) BrdU Flow Kit Staining
Protocol (BD PharMingen, cat. no.: 559619). Data were acquired using BD
LSRII and analyzed with FlowJo.
For flow cytometry on organoid cultures, Matrigel was digested in 1 U of dis-
pase (Becton Dickinson) to release the organoids, followed by 0.05% trypsin,
and strained through a 70-mm filter. Dead cells and lineage-specific cells
(CD31+, Ter119+, and CD45+, as described previously; Plaks et al., 2013)502 Developmental Cell 34, 493–504, September 14, 2015 ª2015 Elswere excluded. Luminal and basal populations were sorted using antibodies
against EpCAM and CD49f (Shehata et al., 2012). To examine T cells after
depletion of APCs in organoids, Matrigel drops were collected in medium
and left on ice before the dispase and trypsin digestion. Dead cells were
excluded and antibodies against CD11c versus CD90.2, CD4, and CD8 were
used to quantify APCs versus T cells, respectively.
Th1/Th2Polarization, TCell Proliferation Assay, andCo-culturewith
Organoids
Lymph node cells or splenocytes from OT-II or OT-II 3 CD2-RFP 3 4get
mice were cultured in RPMI (Life Sciences/GIBCO) with 10% fetal calf serum
(FCS) (Hyclone, Thermo Scientific). Culture for Th1 differentiation: 0.5 mg/ml
anti-CD28 (clone PV-1), 10 mg/ml anti-IL-4 (clone 11B11), 10 ng/ml IL-12,
2.5 U/ml IL-2 (Peprotech), and 1 mg/ml OVA peptide 323–336 (GenScript).
For Th2 differentiation: 0.5 mg/ml anti-CD28, 10 mg/ml anti-IFNg (clone
XMG1.2), 20 ng/ml IL-4 (Peprotech), 2.5 U/ml IL-2, and 1 mg/ml OVA peptide.
Th1/Th2 polarization was confirmed by intracellular Th1/Th2 cytokine stains
(as in for Figure S5A) or by GFP expression indicative of Th2 cytokines, using
the 4get IL-4 reporter mice. Th1/Th2 helper cells were enriched using the
EasySep Mouse CD4 Enrichment kit (StemCell Technologies), and 1 mM
eFluor670 cell proliferation dye was used for helper T proliferation assays.
105 naive or activated OT-II cells per well (stimulated with pOVA, 1mg/ml, as
indicated in Figure S4B) were co-cultured in organoid medium containing
10 U/ml human IL-2.
Spinning Disk Time-Lapse Confocal Microscopy
Imaging of 3D organotypic culture was performed as described previously
(Ewald et al., 2008). CellTracker Red or Blue (Life Technologies) stained the
mammary epithelium. Quantification was done using ImageJ.
RNA Preparation and qRT-PCR Analysis
Basal and luminal mammary epithelial cells sorted from organoids were
extracted for RNA using TRIzol Reagent (Life Technologies). cDNA was
generated using iScript Reverse Transcription Supermix of RT-qPCR (Biorad).
RT-PCR reaction was performed with iTaq Universal SYBR Green Supermix
(Biorad) using ABI 7900 Real Time PCR system. Analysis was normalized to
the housekeeping gene Ppia. Primer sequences used are listed in Supple-
mental Experimental Procedures.
Statistics
Two-tailed unpaired Student’s t test was performed. For comparisons be-
tween more than two groups, one-way ANOVA was used. Statistical signifi-
cance was considered when p < 0.05. Experiments were repeated at least
three times, as indicated in the figure legends. Pooled data are represented
as mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and six movies and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2015.07.015.
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